Apollomics vs Arch Oncology
Apollomics
We are a biopharmaceutical company committed to the discovery and development of mono- and combination cancer therapies
26 employees · est. 2015 · Foster City, United States
Arch Oncology is the older company (2015 vs 2006); Apollomics is the larger of the two.
Side-by-Side Comparison
| Metric | Apollomics | Arch Oncology |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2006 older |
| Headquarters | ||
| Headquarters | Foster City, United States | Brisbane, United States |
| Employees | ||
| Employees | 26 larger | 7 |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post-IPO Equity | Series C |
| Total Funding | ||
| Total Funding | $262.60M | $250.40M |
| Funding Rounds | ||
| Funding Rounds | 5 | 5 |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical CompanyOncology TherapiesCombination TherapiesCancer TreatmentDrug DevelopmentImmune System +8 | Immuno-oncologyAntibody TherapiesClinical-stagePhase 1/2 TrialsSolid TumorsHematologic Malignancies +10 |
| Website | ||
| Website | apollomicsinc.com | archoncology.com |
About Apollomics
Apollomics is a biopharmaceutical company with a clear mission to discover and develop mono- and combination cancer therapies. Established in 2016, Apollomics has made strategic moves to operate in both the U.S. and China, aiming to harness synergies by collaborating with biotechnology companies in...
About Arch Oncology
Arch Oncology is a biotechnology company founded in 2006 and based in the United States. The company is primarily focused on developing groundbreaking antibody therapies for the treatment of solid tumors and hematologic malignancies. Their lead product candidate AO-176 is currently in Phase 1/2 clin...
Also comparing in this category
Comparing more than these two?
Get Apollomics, Arch Oncology and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Apollomics compare?
A PDF of Apollomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Apollomics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Apollomics on 12 Sep 2024, and Arch Oncology on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
